Intelligence Platform

Patents

Browse 3,720 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

US 9096653

Multicomponent vaccine for malaria providing long-lasting immune responses against plasmod

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9095539

Anti-adhesin based passive immunoprophylactic

United States of America as represented by the Secretary of the Air Force · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9095597

N-acetyl mannosamine as a therapeutic agent

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9089515

Long chain N-alkyl compounds and oxa-derivatives thereof

United Therapeutics Corporation · Granted Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9090873

Development of dengue virus vaccine components

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9084761

Use of interleukin-15 to treat cardiovascular diseases

THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9084809

Immunogenic capsule composition for use as a vaccine component against Campylobacter jejun

United States of America as represented by the Secretary of the Air Force · Granted Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9084783

Thio compounds

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9084819

Magnetic microstructures for magnetic resonance imaging

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9084820

Magnetic microstructures for magnetic resonance imaging

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9085604

Antiproliferative factor and methods of use

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9079974

GH-RH analogs with potent agonistic effects

THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Tue Jul 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9079936

Derivatives of APF and methods of use

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Tue Jul 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9072716

Methods of treating and preventing inflammatory bowel disease involving IL-13 and NKT cell

The United States of America, as represented by the Secretary Department of Health by Human Servies · Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9072767

Anti-regurgitation and/or anti-gastrooesophageal reflux composition, preparation and uses

UNITED PHARMACEUTICALS · Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9074185

Adoptive cell therapy with young T cells

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9074195

Nanoparticle entrapment of materials

The United States of America as represented by the Secretary of the Army · Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9072709

Enhancement of bone morphogenic protein (BMP) retention with BMP binding peptide (BBP)

THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9068003

Antibodies that bind to TL1A and methods of treating inflammatory or autoimmune disease co

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9068165

Therapeutic applications of P53 isoforms in regenerative medicine, aging and cancer

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9066948

Oxadiazolo[3,2-a]pyrimidines and thiadiazolo[3,2-a]pyrimidines

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9066965

Purified limonin glucoside for prevention and treatment of chronic diseases

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9056907

Human domain antibodies against components of the human insulin-like growth factor (IGF) s

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9056068

Vaccine and methods of use against Strongyloide stercoralis infection

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)